Wed.Mar 19, 2025

article thumbnail

Q&A: How the COVID-19 Pandemic Changed the Landscape of Pharmacy

Drug Topics

Jeffrey Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, reflects on the COVID-19 pandemic 5 years later.

363
363
article thumbnail

Which Social Media Analytics Matter Most in Pharma Marketing

Pharma Marketing Network

Introduction Social media has become an essential tool for pharmaceutical marketing. However, simply posting content is not enough. To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. But which metrics truly matter? With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Semaglutide, TRT Advertising Contributing to Normalization of Use

Drug Topics

Researchers explored how social media advertising of lifestyle drugs contributes to the normalization of use for semaglutide, testosterone, and sildenafil.

315
315
article thumbnail

The key factors shaping China’s biopharma boom

PharmaVoice

Chinese companies are involved in one-fifth of pharma’s clinical development programs, but trade wars and regulatory hurdles could stymie dealmaking.

147
147
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

PBMs, Manufacturers Increased Lobby Spending in 2024

Drug Topics

In an Axios analysis of US Senate lobbying disclosures from the past year, researchers explored the ongoing trends of how certain industries distribute influence among legislators.

315
315
article thumbnail

Audience Engagement Strategies for Pharma Marketing: Boost HCP and Patient Interaction

Pharma Marketing Network

Introduction In the highly regulated pharmaceutical industry, audience engagement is more than just a marketing goalit is a necessity for building trust with healthcare professionals (HCPs) and patients. But how can pharma brands create meaningful connections in a digital landscape crowded with content? Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation.

More Trending

article thumbnail

Initial leap of faith inspires today’s fast-growing digital clinical trial movement

pharmaphorum

Explore how Tufts Center for the Study of Drug Development (CSDD) has spearheaded the growth of digital clinical trials through an initial leap of faith. Learn more about todays fast-growing movement in the field.

93
article thumbnail

CGM Could Help Management of Diabetic Ketoacidosis

Drug Topics

A recent study found that continuous glucose monitors could help improve patient comfort, reduce resource use, and improve outcomes.

247
247
article thumbnail

Sarepta slumps on Elevidys patient death

pharmaphorum

The death of a patient treated with Sarepta's Duchenne muscular dystrophy gene therapy Elevidys has hit its share price

89
article thumbnail

Building Trust During the COVID-19 Pandemic Is Essential for Pharmacists, Patients

Drug Topics

Jade Ranger, PharmD, discusses her experiences during the COVID-19 pandemic as one of the first pharmacies to receive the COVID-19 vaccines.

Vaccines 190
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Top officials first aimed to slash everything within 48 hours. It has since backtracked and says the HIV Prevention program may be reorganized into HRSA, or less drastically cut.

88
article thumbnail

PBMs, Pricing, and Policy: The Fight for Fair Access to GLP-1s

Pharmacy Times

As demand for GLP-1 therapies grows, patients face rising costs and restrictive insurance policies.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Optum Rx announced on Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs. | Optum Rx announced on Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs.

87
article thumbnail

New Data on HIV-1 Treatments, Including Biktarvy and Novel Lenacapavir Combination Regimen, Presented at CROI 2025

Pharmacy Times

Results highlight promising advancements in novel treatments for patients with HIV-1, including a combination regimen with broadly neutralizing antibodies and long-term data on bictegravir, emtricitabine, and tenofovir alafenamide (Biktarvy).

73
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Urgent care provider CityMD inked a multi-year partnership with Notable to integrate artificial intelligence and automation technology into its nearly 200 clinics.

77
article thumbnail

FDA Grants Orphan Drug Designation to Exidavnemab for Multiple System Atrophy

Pharmacy Times

Exidavnemab is a novel monoclonal antibody with disease-modifying potential.

FDA 73
article thumbnail

Google promises new AI models for drug discovery

pharmaphorum

Google has said it will release new open-source AI models for drug discovery, TxGemma, through a developers' programme later this month

72
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Renovations, recruitment and technology adoption are timed to stand up the in-house Mass General Brigham Cancer before a long-standing partnership with the Dana-Farber Cancer Institute concludes in fall 2028.

71
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Cargo Therapeutics ends development efforts

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. A bunch of my colleagues are traveling to New York today to get ready for our Breakthrough East Summit happening tomorrow.

70
article thumbnail

Sacklers to pay up to $7bn in Purdue Pharma’s opioid settlement plan

Pharmaceutical Technology

Purdue Pharmas new bankruptcy plan outlines the payment structure of the largest opioid settlement to date.

69
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Cigna has officially sealed the deal on the $3.3 billion sale of its Medicare business to Health Care Service Corporation. | Cigna has officially sealed the deal on the $3.3 billion sale of its Medicare business to Health Care Service Corporation.

68
article thumbnail

Novartis sheds staff as Entresto patent expiry looms

pharmaphorum

Novartis will cut 427 jobs this year in the US as it prepares for the loss of market exclusivity for its blockbuster heart failure therapy Entresto

66
article thumbnail

Pembrolizumab in Combination With Platinum-, Fluoropyrimidine-Based Chemotherapy Receives FDA Approval for GEJ

Pharmacy Times

The combination was approved for treatment of patients with gastroesophageal junction (GEJ) adenocarcinoma.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Fierce Healthcare unveiled its seventh annual Fierce 15 earlier this month, introducing th | Executive Editor Heather Landi and Senior Writer Paige Minemyer sit down to chat about the evolution of the Fierce 15 project and honorees.

63
article thumbnail

Age and Comorbidities Drive RSV Hospitalization Rates in Older Adults

Pharmacy Times

Prioritizing preventive measures for high-risk individuals would effectively address half of RSV hospitalizations.

article thumbnail

Roche taps Oxford BioTherapeutics for cancer drug discovery

pharmaphorum

Oxford BioTherapeutics has lined up another big pharma partner for its drug discovery platform, signing a $1bn deal with oncology giant Roche

59
article thumbnail

Depemokimab Suppresses Blood Eosinophil Counts in Adults With CRSWNP

Pharmacy Times

Approximately 74% of patients with chronic rhinosinusitis with nasal polyps receiving depemokimab across 2 trials did not need additional intervention.

65
article thumbnail

Allogeneic cell therapies “poised for prime time” says expert

Pharmaceutical Technology

While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing interest.

59
article thumbnail

Onye Ononogbu, PharmD, MPH, BCOP, Discusses Her Journey to Advance Health Equity and Patient Care Through Research

Pharmacy Times

Ononogbu discusses research, health equity, and sickle cell advancements.

article thumbnail

USPTO allows patents for Remedy’s large hemispheric infarction drug

Pharmaceutical Technology

The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals Cirara, aimed at treating LHI.

59
article thumbnail

FDA Grants Orphan Drug Designation to Radiprodil for GRIN-Related Neurodevelopmental Disorder

Pharmacy Times

Patients with a disorder from this family of neurodevelopmental conditions face a lack of approved treatment options, making radiprodil poised to transform the treatment paradigm.

FDA 65
article thumbnail

Access USA 2025: Spreading Awareness of Medicare Part D Reforms

Pharmaceutical Commerce

The conferences first panel offers insight on the current state of awareness among beneficiaries of the Part D cap and Medicare Prescription Payment Plan via the PAN Foundations latest research.

59
article thumbnail

Arbor to advance gene editing treatments with $73.9m funding

Pharmaceutical Technology

Arbor Biotechnologies has closed $73.9m for its gene editing therapeutic pipeline aimed at liver and central nervous system diseases.

59